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ABSTRACT
The Escherichia coli soxRS regulon activates oxidative
stress and antibiotic resistance genes in two transcriptional stages. SoxR protein becomes activated in cells
exposed to excess superoxide or nitric oxide and then
stimulates transcription of the soxS gene, whose
product in turn activates 10 regulon promoters.
Purified SoxR protein is a homodimer containing a pair
of [2Fe-2S] centers essential for soxS transcription
in vitro. The [2Fe-2S] centers are thought to be
anchored by a C-terminal cluster of four cysteine
residues in SoxR. Here we analyze mutant SoxR
derivatives with individual cysteines replaced by
alanine residues (CysAla). The mutant proteins in
cell-free extracts bound the soxS promoter with
wild-type affinity, but upon purification lacked Fe or
detectable transcriptional activity for soxS in vitro.
Electron paramagnetic resonance measurements in vivo
indicated that the CysAla proteins lacked the [2Fe2S] centers seen for wild-type SoxR. The CysAla
mutant proteins failed to activate soxS expression
in vivo in response to paraquat, a superoxide- generating
agent. However, when expressed to 5% of the cell
protein, the CysAla derivatives increased basal soxS
transcription 2–4-fold. Overexpression of the
Cys119Ala mutant protein strongly interfered with
soxS activation by wild-type SoxR in response to
paraquat. These studies demonstrate the essential
role of the [2Fe-2S] centers for SoxR activation in vivo;
the data may also indicate oxidant-independent mechanisms of transcriptional activation by SoxR.
INTRODUCTION
Bacteria regulate many genes in response to imbalances in the
production and disposal of reactive oxygen species; such
conditions are often called ‘oxidative stress’ (1). In Escherichia
coli, a set of 12 dispersed promoters under the control of the
soxRS locus is activated when cells are exposed to sublethal levels
of compounds, such as paraquat (PQ) (2,3), which generate
intracellular superoxide, or to nitric oxide (4,5). This soxRS

regulon controls antioxidant functions [e.g. superoxide dismutase
or glucose-6-phosphate dehydrogenase (1)], repair of oxidative
DNA damage [endonuclease IV (1)] and antibiotic resistance
genes [micF (6) or acrAB (7)]. The soxRS system may also
provide resistance to the toxicity of organic solvents and some
heavy metals (8). The soxRS regulon is switched on in two
transcriptional stages: existing SoxR protein is activated by an
intracellular redox signal and triggers transcription of the soxS
gene; the resulting SoxS protein binds and activates transcription
from the various regulon promoters (1).
SoxR protein is the master regulator of the soxRS response
(9,10). SoxR in vitro binds and strongly stimulates transcription
of the soxS promoter by the exponential-phase RNA polymerase
(RNAP) containing the 70 protein (11). The activity of SoxR as
a transcription factor is completely dependent on the presence of
non-heme iron in the protein (11). The metal is present in the
active homodimeric SoxR protein as a pair of [2Fe-2S] clusters,
which are in the oxidized form when the protein is isolated from
cells (12,13). SoxR activity can be regulated either by the
assembly and disassembly of its iron–sulfur clusters (14,15) or by
oxidation–reduction of the [2Fe-2S] centers, with the oxidized
protein being the transcriptionally active form in vitro (16,17).
Recent in vivo experiments support the interpretation that reduced
SoxR is transcriptionally inactive (18).
From the foregoing it is clear that the [2Fe-2S] centers in SoxR
are intimately involved in the protein’s function as a transcription
regulator in vitro, but their in vivo importance has not been
validated. Attempts to control iron availability are complicated by
the essential roles of Fe in other proteins, and by the complex
regulation governing the assimilation and storage of this metal
(19). Initial spectroscopic analysis indicates that each [2Fe-2S]
center in SoxR is anchored by four thiol ligands, which accounts
for the four cysteine residues present in each protein monomer
(12,13). In this work we have tested the biological role of the
[2Fe-2S] centers by mutating the individual cysteine residues of
SoxR. These mutations eliminate the activation of SoxR by
oxidative stress in vivo and prevent the assembly of stable
iron–sulfur centers in the protein, but still allow a significant level
of basal SoxR activity when the mutant proteins are expressed at
high levels.
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MATERIALS AND METHODS
Strains and plasmids
This work employed the E.coli K-12 strains carrying single copy
operon fusions present in lysogenized phage : strain TN521, a
derivative of GC4468 (2) but soxRS::zjc2205-kan (soxR+
soxS::lacZ) (20); and strain TN5311, as TN521 except
(soxR soxS::lacZ) (20) and containing F proAB lacIq
lacZM15::Tn10 (21), transferred from XL1-blue (Stratagene,
La Jolla, CA) by conjugation. The pBluescript plasmid was from
Stratagene and does not contain an inducible promoter for
recombinant gene expression. The plasmid pSE380 contains the
lacIq gene and the lac repressor-regulated trc promoter for
controlled expression of recombinant genes (Invitrogen, San
Diego, CA). The plasmid pKEN2 [a generous gift of G. Verdine,
Harvard University (11)] contains a lac-regulated derivative of
the tac promoter for controlled expression of recombinant genes
but does not contain its own lacI gene; expression from
pKEN2-derived plasmids is regulated by chromosomal lacI.
Construction of cysteine-to-alanine mutations
Four mutant soxR genes, each encoding an alanine residue
substituting for a SoxR cysteine (residues 119, 122, 124 and 130),
were constructed by using a plasmid containing the soxRS locus
[pBD100; (22)] as a template for sequential rounds of polymerase
chain reaction (PCR). For the first round of amplification, primers
T3 (5-ATTAACCCTCACTAAAG-3) and T7 (5-AATACGACTCACTATAG-3), specific for sequences in the
pBluescript KS vector were used together with mutagenic
primers converting the cysteine codon (TGT or TGC) to an
alanine codon (GCT or GCC; underlined below).
a) C119A 5-GAACTGGACGGAGCTATTGGTTGTGG-3
b) C119A 5-CCACAACCAATAGCTCCGTCCAGTTC-3
c) C122A 5-GATGTATTGGTGCTGGCTGCCTTT-3
d) C122A 5-AAAGGCAGCCAGCACCAATACATC-3
e) C124A 5-TGCGCGAAAGGGCGCCACAACCAA-3
f) C124A 5-TTGGTTGTGGCGCCCTTTCGCGCA-3
g) C130A 5-CAGTGATGCCCCGTTGCGTA-3
h) C130A 5-TACGCAACGGGGCATCACTG-3
Overlapping PCR products were generated using the pairs of
primers, pBD100 (10 ng) as the template, and 1 U cloned Pfu
DNA polymerase (Stratagene) and isolated from the reaction
mixtures using a commercially available spin column (Qiagen,
Chatsworth, CA). Approximately 10 ng of each pair of overlapping
soxR fragments were then combined with 50 pmol of the T3 and
T7 primers in a 100 l reaction mixture. After denaturation and
reannealing of the overlapping complementary cysteine coding
regions, PCR yielded fragments (728 bp) containing the full-length
mutated genes. These were purified and digested with EcoRI and
HindIII (New England Biolabs, Beverley, MA), electrophoresed
in a 1% agarose gel in Tris-acetate/EDTA buffer (23) and
recovered from gel slices using DEAE membranes (Schleicher
and Schuell, Keene, NH). The purified fragments were subcloned
into EcoRI/HindIII-digested pBluescript and transformed into
XL1-Blue cells. Transformants were selected on LB agar plates
(21) containing 75 g/ml ampicillin, 15 g/ml tetracycline and
the LacZ+ indicator 5-bromo-4-chloro-3-indolyl--D-galactopyranoside (21). White colonies were selected and analyzed by
PCR using the T3 and T7 primers to verify the presence of

full-length soxR in the plasmids. Plasmid DNA was purified from
positive clones and both strands of the soxR inserts completely
sequenced by the dideoxy chain termination method (23) using
Sequenase II (US Biochemical) and the following primers: T3, T7,
SRKR (5-GGGCAACACGCCAAACGCT-3), SRKF (5AGCGTTTGGCGTCTTGCCC-3),
E4
(5GCGCGGATCCCAGC- GGCGATATAAA-3) and E5K (5GCGCGAGCTCGCTTTCG- TCCCAATGG-3).
The four mutant cysteine sequences were subcloned from the
pBluescript vectors into pKEN2, generating the plasmids
pKENC119A, pKENC122A, pKENC124A and pKEN130A.
The C119A mutant gene was also subcloned into pSE380 to
generate pSEC119A for subsequent studies. Despite several
attempts, stable insertion of the other cysteine mutant genes into
pSE380 was unsuccessful.
Preparation of whole cell homogenates and partially
purified protein
Plasmids derived from pKEN2 were transformed into E.coli strain
TN5311 and grown in 200 ml LB broth (21) containing 75 g/ml
ampicillin, 15 g/ml streptomycin and 15 g/ml kanamycin to
OD600  0.5–1. Isopropyl--D-thio-galactopyranoside (IPTG)
was then added to a final concentration of 0.5 mM, and the
incubation was continued for 120 min at 307 C. The cells were
harvested by centrifugation at 10 000 g at 40 C, resuspended and
washed three times with ice-cold M9 salts (21). The final cell
pellet was resuspended to a volume of 1.0 ml with 50 mM
HEPES–NaOH, pH 7.6, 0.1 M NaCl, and lysed by agitation with
glass beads (400 l beads/ml) in a Mini-bead beater (Biospec
Products, Bartlesville, OH) for 3 min. Following centrifugation
at 10 000 g for 45 min at 40C, the supernatants were collected and
frozen at –200C or –80 0C until assay. Cell extracts were resolved
on 15% SDS–polyacrylamide gels (24) and stained with Coomassie
blue as previously described (11).
SoxR mutant proteins were also extensively purified using
DE52–Sepharose and heparin–agarose column chromatography
as described previously (11).
Iron and protein determinations
The Fe content of partially purified SoxR proteins (11) was
determined by inductively coupled plasma emission spectrometry at
the Chemical Analysis Laboratory, Institute of Ecology, University
of Georgia (Athens, GA). SoxR concentrations were estimated by
scanning densitometry analysis (Visage System, Millipore,
Milford, MA) of Coomassie blue-stained SoxR in SDS–polyacrylamide gels (24) using a SoxR standard previously quantified by
amino acid analysis.
DNA–protein binding
The binding affinity of wild-type and mutant SoxR proteins for
the soxS promoter in vitro was analyzed by electrophoretic
mobility shift assays, as previously described (9,11).
Preparation of cell suspensions
TN5311 transformed with the expression plasmid pKEN2 or its
soxR-containing derivatives pKOXR [containing the wild-type
soxR gene; (22)], pKENC119A, pKENC122A, pKENC124A or
pKENC130A were grown overnight in LB broth containing
ampicillin (100 g/ml). A fresh 125-ml aliquot of the same
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Figure 1. Location of [2Fe-2S] cluster and cysteine replacements in SoxR protein.

medium was in oculated with 1.25 ml of overnight culture and
incubated at 37 0C with shaking at 250 r.p.m. for 110 min. IPTG
was added to a f inal concentration of 0.5 mM, and the incubation
continued at 370C with shaking for an additional 120 min. The
cells were harvested by centrifugation and resuspended in 0.5 ml
of 50 mM HEPES–NaOH, pH 7.6, 0.1 M NaCl. Freshly dissolved
dithionite, 0.1 M dithionite in 1 M HEPES–NaOH pH 7.6, was
then added to the cell paste to a final concentration of 1 mM.
Aliquots (300–400 l cell paste) were immediately placed inside
4 mm EPR sample tubes, frozen in liquid nitrogen and kept at
–800 C until analysis. The total SoxR concentration in the cells
was determined by Western blot analysis of samples lysed
directly in sample buffer (24), using previously quantified SoxR
as a standard.
Immunological methods
Wild-type E.coli SoxR protein was purified to near homogeneity
as described previously (11). The purified protein was emulsified
in complete Freund’s adjuvant and injected subcutaneously into
two New Zealand black rabbits. Starting three weeks after the
primary injection, the rabbits received booster injections every 2
weeks with similar SoxR preparations in incomplete Freund’s
adjuvant. Polyclonal antisera were extracted periodically starting
4 weeks after the first injection, and SoxR-specific antibodies
were enriched by affinity chromatography using SoxR-columns
generated by coupling purified SoxR protein to HiTrap NHSactivated columns (Pharmacia) according to the conditions
recommended by the supplier. Polyclonal serum was applied to
the columns and SoxR-specific antibodies eluted following
standard procedures (25).
For immunoblotting, samples of cell suspensions or purified
SoxR were electrophoresed in SDS–polyacrylamide gels, and
transferred to nitrocellulose membranes (Schleicher and Schuell,
Keene, NH) with a TE series Transphor electrophoresis unit
(Hoefer Scientific, San Francisco, CA). The filters were probed with
the affinity-purified antisera and bound antibody was detected
with alkaline phosphatase-conjugated anti-rabbit IgG antibodies
(Promega, Madison, WI).
EPR spectroscopy
X-band EPR spectra were recorded at 20 K on a Bruker model
ESP300 spectrometer maintained at constant temperature, with
an Oxford Instruments model ESR910 continuous flow cryostat
as described previously (14,15). The amount of reduced SoxR
was determined by comparison in the same experiment to
standardized Fe-SoxR samples after reduction with dithionite

(13,14). The high EPR background noise of the cell paste was
greatly reduced by electronically subtracting from the spectra for
SoxR-containing samples the spectrum of TN5311-pKEN2 cells,
which do not express SoxR.
In vitro transcription
The activity of wild-type and mutant SoxR proteins was
determined by in vitro transcription of the soxS gene by
commercial E.coli RNA polymerase accompanied by the indicated
amounts of SoxR, as described previously (13,14).
-Galactosidase assays
The ability of the mutant proteins to stimulate soxS transcription
in vivo was assessed using TN521 and TN5311. TN5311 cells
were transformed either with the pBluescript-based plasmids for
low-level SoxR expression, or with the pKEN2-based plasmids
for high-level expression. TN521 cells were also transformed
with the pSEC119A plasmid. Overnight cultures of the indicated
strains were diluted 1:100 (or in some experiments 1:1000) into
fresh LB broth containing 50 g/ml ampicillin and treated as
follows. For TN5311 containing pBluescript-based plasmids, PQ
was added to a final concentration o f100 M to one aliquot at
OD600  0.4, and incubation at 37 C0 continued 60 min. For
TN5311 containing pKEN2-based plasmids, when the cell
density approached OD600  0.1, IPTG was added to a final
concentration of 0.5 mM and after 60 min PQ was added as above.
For TN521 containing pSE380 or pSEC119A, IPTG was added
(to 0.5 mM) at OD600  0.05. Aliquots of the cultures were
removed at 0, 30 or 60 min following IPTG addition, PQ added
(final concentration 250 M) and the incubation continued 30 min
before harvesting for the assay. -Galactosidase activity was
assayed in SDS/CHCl3-treated cells as described by Miller (21).
RESULTS
Both strands of the four soxR CysAla mutant genes were
sequenced to verify the presence of the mutant codons. Each of
the four mutant alleles contained the desired mutations
(TGTGCT or TGCGCC) (Fig. 1) that reprogrammed the
cysteine codon to an alanine codon. The full-length sequences of
the four mutant constructs showed that no additional mutations
were introduced by the site-specific procedure.
In vitro properties of SoxR CysAla mutant proteins
SoxR proteins for in vitro characterization were overexpressed in
TN5311 cells (soxRS) transformed with pKEN2-derived
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mutants lacked the near-axial resonance spectrum characteristic
of reduced wild-type Fe-SoxR (12–15), while such a spectrum
was easily seen in cells overexpressing the wild-type protein (Fig.3).
For the wild-type protein overexpressed in vivo in the absence of
PQ treatment, 36% was detected as the reduced Fe-SoxR form,
consistent with other experiments performed in a similar manner
(18).
From the foregoing results, there was no indication that the
mutant proteins contained [2Fe-2S] centers in vivo, although the
unlikely possibility remains that such centers are present but
remain in an EPR-silent (oxidized?) state. In vitro transcription
assays (14) showed that the CysAla mutant proteins were
devoid of transcriptional activity for the soxS gene, and behaved
similarly to apo-SoxR (Fig. 4). As found for the crude extracts
(Fig. 2B), binding activity of the purified mutant proteins for the
soxS promoter was indistinguishable from that of wild-type SoxR
(data not shown). Thus, the CysAla mutant proteins neither
have tightly bound [2Fe-2S] centers nor function as specific
transcription factors for the soxS gene in vitro.
In vivo properties of the CysAla mutant proteins

Figure 2. (A) Coomassie blue-stained SDS–polyacrylamide gel of protein
extracts from TN5311 cells overexpressing wild-type and mutant SoxR
proteins. SoxR, 1 or 0.5 g purified wild-type SoxR protein. Cell extracts (15g):
WT, pKOXR plasmid; –, pKEN2 plasmid; C1, pKENC119A plasmid; C2,
pKENC122A plasmid; C3, pKENC124A plasmid; C4, pKENC130A plasmid.
, the electrophoretic position of purified SoxR. (B) Binding activity for soxS
promoter DNA SoxR-containing cell extracts. Lane 1, DNA alone; lane 2,
vector control (5 g); lanes 3 and 4, wild-type SoxR extract (WT); lanes 5 and 6,
SoxR-C119A extract (C1); lanes 7 and 8, SoxR-C122A extract (C2); lane 9 or
10, SoxR-C124A extract (C3); lanes 11 and 12, SoxR-C130A extract (C4); odd
numbered lanes correspond to 0.5 g extract protein, even numbered lanes to
5 g. C, SoxR–DNA complex; D, free DNA.

vectors encoding either wild-type SoxR (pKOXR) or the
respective mutant proteins encoded by pKENC119A,
pKENC122A, pKENC124A and pKENC130A. SDS–PAGE
analysis of cell extracts demonstrated the presence of similar
amounts of the wild-type and the four cysteine mutant proteins,
each with Mr = 17 000 (identical to that of wild-type SoxR; Fig. 2A).
We sought to determine whether elimination of the cysteine
residues might impair the ability of the mutant proteins to bind
soxS promoter DNA in vitro in electrophoretic mobility shift
assays (EMSA) (11). Cell-free extracts containing wild-type and
mutant SoxR proteins displayed similar levels of soxS binding
activity in vitro that increased with the amount of extract protein
added (Fig. 2B). The mutant and wild-type proteins therefore
bind the soxS target with similar affinities, since the proteins were
present at similar levels in the extracts (Fig. 2A).
Since the CysAla mutant SoxR proteins retained DNA
binding activity, all four proteins were extensively purified (to
90% homogeneity), in parallel with wild-type SoxR and in
similar yield (data not shown). The purified mutant proteins each
lacked the visible absorbance characteristic of oxidized Fe-SoxR
and had no significant Fe detectable by inductively coupled
plasma emission spectrometry (<0.1 atom Fe per SoxR monomer;
data not shown). It seemed possible that the CysAla mutant
proteins might contain iron in vivo, but lose the metal during
purification. Analysis by EPR spectroscopy of intact cells
overexpressing the various proteins showed that all the CysAla

In view of the lack of transcriptional activity of the mutated SoxR
proteins in vitro, we wished to determine whether the CysAla
mutant proteins retained ability to induce regulated expression of
the soxS gene in vivo. For this purpose we used a soxRS strain
harboring a single copy of the soxS::lacZ fusion (TN5311), in
which expression of -galactosidase activity encoded by the
fusion depends on the in vivo activity of SoxR expressed in trans
(20,26). The in vivo effectiveness of the mutant SoxR proteins
was initially examined using constructs in the pBluescript vector,
which lacks a strong inducible promoter and expresses wild-type
SoxR at a level similar to cells containing a single soxR+ allele in
the genome (E.H. and B.D., unpublished data). All four mutant
proteins failed to increase -galactosidase activity above the
basal level observed with the vector alone, even when the
cells were grown in the presence of PQ, which strongly
activated soxS expression in cells with wild-type SoxR (14fold; Fig. 5A).
The results were somewhat different when intracellular SoxR
concentrations were elevated (to 5% of the total cell protein)
using the high level expression vector pKEN2 (11,13) (see Fig. 2A
for SoxR protein levels). Wild-type SoxR (expressed from this
vector) yielded 19-fold soxS activation in response to PQ (Fig. 5B),
giving an induced level of -galactosidase expression nearly
twice that seen for cells bearing the wild-type pBluescript
construct (Fig. 5A). Thus, the normal intracellular concentration
of SoxR may be limiting for soxS activation in some situations.
In contrast, cells overexpressing the mutant proteins from the
pKEN2 vector exhibited elevated soxS expression that was not
affected by PQ (Fig. 5B). For three of the mutant proteins
(C119A, C122A and C124A) the level of soxS::lacZ
expression was 4-fold higher than the basal (uninduced)
expression mediated by wild-type SoxR; for the C130A
protein, basal expression was 2-fold higher (Fig. 5B). The
CysAla mutant proteins have therefore lost responsiveness to
the redox signal generated by PQ, but can exert a higher basal
transcriptional activity than wild-type SoxR.
It seemed possible that expression of the mutant proteins might
interfere with wild-type SoxR, either through the formation of
heterodimers or by competition for binding the soxS promoter. At
low levels of mutant SoxR expression (from the pBluescript
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Figure 3. EPR analysis of SoxR in vivo. The EPR spectra of cell suspensions were recorded as described previously for purified Fe-SoxR (13). The intracellular SoxR
concentration [SoxR] was estimated by immunoblotting of whole cell extracts (see Materials and Methods). The content of reduced [2Fe-2S] SoxR in the cells was
estimated from the amplitude of the EPR resonance at gy (15) normalized to a known preparation of purified SoxR.

-galactosidase from soxS::lacZ was increased to 1000 U
in cells overexpressing the C119A protein.
DISCUSSION

Figure 4. SoxR-dependent in vitro transcription of soxS. Fe-SoxR (active),
apo-SoxR (inactive) or CysAla mutant proteins (5 ng each) were incubated
with 100 nM RNAP in in vitro transcription reactions containing a plasmid
carrying both the SoxR-dependent soxS gene and the SoxR-independent bla
gene as indicated in Materials and Methods. The corresponding primer
extension reactions (13,14) for the soxS and bla transcripts are indicated.

vectors), induction of soxS by wild-type SoxR in response to PQ
was unaffected (data not shown).
An additional study was conducted to assess the effect of
overexpressing one of the mutant proteins (C119A) on the
inducibility of soxS in TN521 (soxR+) cells. Because this strain
harbors only the lacI+ allele, we used the vector pSE380 (bearing
lacIq; see Materials and Methods) to achieve tightly regulated
SoxR expression inducible by IPTG. After 1000-fold dilution of
overnight cultures into fresh medium and outgrowth for 60 min,
IPTG was added, followed at various times by a 30 min exposure
to PQ (250 M) to measure activation of soxS transcription. The
induction of soxS::lacZ by PQ was essentially the same for
both the vector control (pSE380) and the strain
overexpressing wild-type SoxR (from pSXR) throughout the
course of the experiment (Fig. 6). In contrast, the expression
of the C119A protein strongly interfered with soxS induction,
even at the earliest time point (some leaky expression of SoxR
is expected even in the absence of IPTG). PQ inducibility was
completely eliminated after only a 30 min pre-induction of the
mutant protein with IPTG (Fig. 6). As seen in Figure 5B, basal
expression of

Our previous work established that the SoxR [2Fe-2S] centers are
essential for the protein’s transcriptional activity at soxS in vitro
(11,13–15). Here, we have extended the demonstration of this
requirement to the activity of SoxR in vivo by engineering mutant
genes that direct the synthesis of SoxR derivatives with individual
cysteine residues replaced by alanines. For at least the C119A
derivative, high level synthesis interfered with the normal activity
of SoxR during activation by PQ. Despite their inability to be
activated by oxidative stress, overexpression of the CysAla
SoxR proteins revealed an unexpectedly high level of basal
transcriptional activity in vivo that was not detected in vitro.
Removal of the SoxR [2Fe-2S] clusters in vitro by aerobic
exposure of the protein to 2-mercaptoethanol (11,13) or the
biological thiol glutathione (15) eliminates the transcriptional
activity at soxS without any apparent effect on SoxR protein
stability, oligomeric state or binding affinity for the soxS
promoter. Elimination of detectable metal binding by CysAla
replacements effectively blocked SoxR activation in response to
PQ and did not significantly affect protein expression in vivo or
soxS binding in vitro. These observations provide new evidence
for post-translational activation of SoxR, and show that this
activation in vivo depends critically on the integrity of the
[2Fe-2S] centers. The results also support the conclusion from
EPR spectroscopy that all four SoxR cysteine residues are
involved in anchoring the metal center. Efforts to assemble
[2Fe-2S] centers into the Cys119Ala protein in vitro were
unsuccessful (14).
Re-insertion in vitro of [2Fe-2S] centers into wild-type apoSoxR restored full transcriptional activity (14). However, the
properties of the CysAla mutant proteins alone do not resolve
whether the critical step for SoxR activation in vivo is synthesis
of the [2Fe-2S] centers or a subsequent redox reaction. We have
previously suggested (13,14) that these two steps might be linked
if the stability of the metal centers is influenced by oxidation and
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Figure 6. Interference of SoxR-C119A protein with wild-type SoxR in vivo.
The bottom lines indicate the plasmid present (pSE380, control; pSXR, wild-type
SoxR; pSEC119, SoxR-C119A) in strain TN521 (soxR+ soxS::lacZ), the time
of IPTG treatment to induce recombinant SoxR, and exposure to PQ (+).
-Galactosidase activity is shown in units (21). All values represent the
mean of three independent samples, except pSEC119/0 min/no PQ, for which
only two samples were available.

Figure 5. Expression of soxS::lacZ as a function of mutant SoxR
expression in strain TN5311 (soxR). (A) Low level expression via uninduced
pBluescript vectors or (B) high level expression via induced pKEN2 vectors.
+, incubation with PQ; –, non-exposed cells. -galactosidase activity is
expressed as Miller units (21).

reduction. However, recent experiments (16,17) indicate that
SoxR with reduced [2Fe-2S] centers is stable, but transcriptionally
inactive in vitro. In vivo studies of the properties of constitutive
forms of SoxR extend this model to living cells (18).
For wild-type SoxR, the quantity of reduced [2Fe-2S] centers
detected in untreated cells corresponded to only 36% of the total
SoxR protein (Fig. 3). The EPR-silent forms include both
oxidized and apo-SoxR (12,13), with only the former active in
vitro (11,16,17). The in vivo EPR analysis shown here and
elsewhere (18) thus supports the conclusion that reduced FeSoxR is transcriptionally inactive in cells. Some oxidation
evidently occurs during sample preparation by the method
employed here: using a modified method (H.D. and B.D.,
manuscript in preparation), we have measured levels of reduced
wild-type protein representing 95% of the total SoxR.
Two additional features of the SoxR CysAla mutants merit
mention. First, during activation by PQ, none of the substituted
forms, when expressed at approximately wild-type levels,
competed detectably with wild-type SoxR expressed from a
single-copy gene; such interference was observed only upon high
level expression of the C119A derivative. In view of their
evidently normal stability and DNA binding affinity, the relative

ineffectiveness of the mutant proteins in blocking soxS activation
by wild-type SoxR is striking. In principle, the mutant proteins
could interfere with wild-type SoxR in two ways: by the
formation of mixed dimers with a wild-type subunit, or by
competition for binding the soxS promoter. It would thus be of
interest to determine whether the mixed dimers retain partial or
complete function. Regarding the second possible mode of
interference, wild-type SoxR and the CysAla mutant proteins
bound the soxS promoter equally well in vitro (Fig. 2B). However,
RNAP binds the soxS promoter cooperatively with activated
SoxR (11), an effect that could disfavor competition by low levels
of the CysAla mutant proteins.
The second unexpected feature of the CysAla mutant forms
of SoxR was the relatively high basal soxS transcription they exert
upon overexpression in vivo, which contrasts with the essentially
undetectable activity of these proteins in vitro. It remains possible
that the CysAla mutant proteins cause transcriptional activation higher than that of apo-SoxR, but at a level still undetectable
in our in vitro assay. Alternatively, the in vivo activity of the
mutant proteins in the absence of a redox signal could suggest the
existence of additional controls on soxS activation that are overcome
by high concentrations of the CysAla derivatives but not nonactivated wild-type SoxR. The known negative autoregulation by
SoxS (27) is evidently not responsible for this effect, which we
observed in SoxS deficient cells. Previous genetic studies (2,3)
identified regulatory mutations only in soxR and soxS (9,10), but
a smaller effect on soxS expression caused by other mutations
might have been missed. One possible negative regulator is Rob
protein, which is abundant [5000 molecules/cell; (28)] and has
DNA binding specificity that overlaps that of SoxS (29–31).
MarA protein also exhibits overlapping specificity with SoxS
(32), but its expression is kept low through repression by the
MarR protein (33).
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